Bioconjugation of therapeutic proteins and enzymes using the expanded set of genetically encoded amino acids

被引:11
作者
Lim, Sung In [1 ]
Kwon, Inchan [1 ,2 ]
机构
[1] Univ Virginia, Dept Chem Engn, Charlottesville, VA USA
[2] GIST, Sch Mat Sci & Engn, Gwangju 500712, South Korea
基金
新加坡国家研究基金会;
关键词
Bioorthogonal chemistry; drug delivery; immobilization; monoclonal antibody; non-natural amino acid; protein chemistry; protein conjugation; site-specific incorporation; AZIDE-ALKYNE CYCLOADDITION; PHOTO-CROSS-LINKING; SITE-SPECIFIC INCORPORATION; ANTIBODY-DRUG CONJUGATE; DIELS-ALDER REACTIONS; NEWLY SYNTHESIZED PROTEINS; PICTET-SPENGLER LIGATION; FREE CLICK CHEMISTRY; HALF-LIFE EXTENSION; IN-VIVO;
D O I
10.3109/07388551.2015.1048504
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The last decade has witnessed striking progress in the development of bioorthogonal reactions that are strictly directed towards intended sites in biomolecules while avoiding interference by a number of physical and chemical factors in biological environment. Efforts to exploit bioorthogonal reactions in protein conjugation have led to the evolution of protein translational machineries and the expansion of genetic codes that systematically incorporate a range of non-natural amino acids containing bioorthogonal groups into recombinant proteins in a site-specific manner. Chemoselective conjugation of proteins has begun to find valuable applications to previously inaccessible problems. In this review, we describe bioorthogonal reactions useful for protein conjugation, and biosynthetic methods that produce proteins amenable to those reactions through an expanded genetic code. We then provide key examples in which novel protein conjugates, generated by the genetic incorporation of a non-natural amino acid and the chemoselective reactions, address unmet needs in protein therapeutics and enzyme engineering.
引用
收藏
页码:803 / 815
页数:13
相关论文
empty
未找到相关数据